Background
==========

In the adult population, numbers of knee injuries arise every year during sports activities and exercise \[[@b1-medscimonit-19-1080]\]. The most common injuries are ligament sprains, muscle strains, and contusions \[[@b2-medscimonit-19-1080]\]. In the annually recorded 150,000 injuries affecting the knee, the Anterior Cruciate Ligament (ACL) injuries are the most frequently occurring injury.

According to the Sports Medicine Media Guide for 2011, the cost of ACL injuries has been estimated at half a billion dollar annually. Additionally, people who have a history of ACL injury are at a higher risk of potential arthritis later in their life and will cost an additional millions of dollars (Sports medicine media guide, 2011). Previous studies have indicated that women have a 2 to 8 times higher risk factor of knee injuries than men, specifically, involving the ACL \[[@b3-medscimonit-19-1080]--[@b7-medscimonit-19-1080]\]. There has been ongoing debate on why women are more susceptible.

The differences are commonly assumed to be caused by anatomical, neuromuscular, behavior patterns, and hormonal influences that make women more susceptible to ACL injuries \[[@b7-medscimonit-19-1080],[@b8-medscimonit-19-1080]\]. Recently investigators have examined the association between female reproductive hormones and structure material and mechanical properties of the ACL. There has been a common theory of the presence of 17-beta estradiol receptor in ACL for decades. The constant changes in the levels of estrogen during the menstrual cycle have been investigated to see if sex hormones are related to ligament laxity \[[@b9-medscimonit-19-1080]--[@b12-medscimonit-19-1080]\]. Human tendon, muscle, and ligament are composed of collagen fibers closely packed together. Due to the decrease of collagen formation and fibroblast proliferation with an increased estrogen serum concentration, the decreased collagen synthesis causes ligament looseness, weak muscle strength and tendon elasticity all of which makes the ACL more susceptible to injuries \[[@b9-medscimonit-19-1080],[@b10-medscimonit-19-1080],[@b13-medscimonit-19-1080]\]. Estradiol is the estrogens in women and is the most commonly measured estrogen in young non-pregnant females \[[@b14-medscimonit-19-1080]\]. Since most ACL injuries occur in young healthy women, most investigators have used estradiol as the major estrogen biomarker.

However, there has been controversy on the result of ACL laxity changes across the menstrual cycle. A systemic review on the effects of the menstrual cycle on anterior knee laxity by Zazulak et al. showed that only three of the nine studies reported a significant difference on ACL laxity during the menstrual cycle \[[@b5-medscimonit-19-1080]\]. Although this study found limited evidence of the correlation between ACL laxity and sex hormones, Zazulak et al. claimed that cycle phases might have an effect on anterior knee laxity. These researchers suggested that future investigators should consider the limitation in present methodologies that they had discovered \[[@b5-medscimonit-19-1080]\]. They also point out confounding variables that might affect anterior knee elasticity during the menstrual cycle.

Temperature is one of the factors that affects elasticity in muscles \[[@b15-medscimonit-19-1080]\], such that, an increase in tissue temperature by doing a warm-up exercise will increase muscle and tendon extensibility \[[@b16-medscimonit-19-1080]\]. Normal core temperature is maintained between 36--37.5° C \[[@b17-medscimonit-19-1080],[@b18-medscimonit-19-1080]\]. The core temperature shows a fluctuation across the menstrual cycle; it is at a peak during the middle luteal phases while in the early follicular and the ovulation it is relatively low \[[@b19-medscimonit-19-1080]--[@b21-medscimonit-19-1080]\]. Skin temperature of the arms and legs is commonly measured around 6°C below the core, 30--31.5°C since human legs and arms tissues are used as a radiator to remove excess heat from the core \[[@b22-medscimonit-19-1080],[@b23-medscimonit-19-1080]\]. Due to the core temperature changes throughout the menstrual cycle, skin temperature can also be altered because of the core temperature changes. To increase core temperature, arm and leg temperature is reduced at first to conserve heat. To lower core temperature, arm and leg temperature increases to dissipate heat \[[@b24-medscimonit-19-1080]\]. Since, ligament, muscle, and tendon extensibility will decrease and increase with decreased or increased tissue temperature, it is of no surprise that the menstrual cycle has dramatic effects on tissue extensibility. Although tissue extensibility decreases with decreased tissue temperature, many studies have reported that anterior knee laxity is greater in the ovulation phases where the core temperature is comparatively lower than other phases \[[@b25-medscimonit-19-1080],[@b26-medscimonit-19-1080]\]. However, core temperature increases after ovulation. To keep core temperature lower at ovulation, the shell must be dissipating more heat to keep the core cooler \[[@b20-medscimonit-19-1080]\]. Therefore, shell must be warmer after ovulation. These findings may explain that anterior knee laxity changes are a consequence of estrogen fluctuations alone during the menstrual cycle. The reported change may be temperature related to and not a direct effect of estradiol. Thus, the aim of the present study is to examine the relationship between estradiol serum concentration and ACL elasticity, knee flexibility and how this relates to tissue temperature in young healthy women with a regular menstrual cycle.

Material and Methods
====================

Ten non-athletic young healthy females with a regular menstrual cycle participated in this study. They were recruited by word of mouth and selected by their self-reported menstrual cycle. Participants were 18 to 30 years of age with a body mass index (BMI) between 15 and 30 who had a regular menstrual cycle for at least one year ([Table 1](#t1-medscimonit-19-1080){ref-type="table"}). Participants had no history of pregnancy, neuropathy, myopathy or knee injury, and were not taking any medication that could alter sex hormones. The study was approved by Institutional Review Board of Loma Linda University and all participants signed an informed consent.

Trained researchers measured all outcome variables throughout the experiments. The outcome variables assessed were ACL elasticity, force to flex the knee (FFK), knee flexion-extension hysteresis (KFEH), leg skin temperature, and estradiol serum concentration.

Estradiol serum concentration
-----------------------------

Two certified phlebotomists drew 4cc of venous blood samples from each participant's antecubital area with 23-guage needles to determine estradiol serum concentration. The serum was separated from plasma by centrifuging the blood. The centrifuge was set at 3000 rpm for 10 minutes (Beckman Coulter Inc., Brea, CA). The serum was kept at a temperature of −80°C. After all samples of serum were collected, Estradiol serum concentration was assessed using the TOHSO Estradiol ST AIA assay (Fisher Healthcare Inc. Houston, TX).

Leg skin temperature
--------------------

Leg skin temperature was measured using the Forward Looking Infrared 660 IR Camera (FLIR systems, Danderyd, Sweden). This device was validated to accurately detect the temperature of the skin \[[@b27-medscimonit-19-1080]\]. To acquire best images, the readings were at a perpendicular angle and at a distance of one meter away from the skin. Dark colored rooms were preferred to minimize infrared interference so that test was performed in the room with uniform Light Emitting Diode (LED) \[[@b28-medscimonit-19-1080]\]. Baseline leg skin temperature was taken before ACL laxity and quadriceps elasticity measurements after stabilizing leg temperature in a neutral environment for 20 minutes and leg skin temperature was measured immediately when the heat pads at 38°C were removed.

Anterior ligament elasticity
----------------------------

Knee elasticity of ACL was measured by a KT-2000 knee arthrometer (MEDmetric Corp, San Diego, California). This device had been validated for over twenty years in both clinical and research areas \[[@b29-medscimonit-19-1080],[@b30-medscimonit-19-1080]\]. First, the knee was placed in a predetermined position while the participant lays supine. With the knee at 90 degrees, a strain gauge was used to measure the force necessary to generate an anterior glide of the proximal end of the tibia on the femoral condyles. This generated a force curve of elasticity in the anterior cruciate ligaments. The process was accomplished by supporting both limbs with a firm, comfortable platform placed proximal to the popliteal space. This helped keep the patient's knee flexion angle constant for the duration of the test. Along with this device, a foot support accessory supplied with the Arthrometer^®^, positioned the feet symmetrically allowing the leg position to be optimal for the test while reducing external rotation of the tibia. For the most comfortable position during the flexion angle test, knee flexion angle was held at 25 degrees ([Figure 1](#f1-medscimonit-19-1080){ref-type="fig"}). A thigh strap, provided, controlled hip external rotation while offering support that allows patients to be most relaxed. Force used for the experiment was applied at 30 lbs (133N) of force. The output of ACL elasticity was displaced on an X--Y plotter. A vernier caliper was used to interpret anterior tibal displacement (ATD) graph. A single trained investigator measured ACL laxity measures throughout the study to minimize potential inter investigation variation.

Muscle and tendon flexibility
-----------------------------

Muscle and tendon flexibility was measured by a continuous passive motion device (CPM). Participants were asked to sit on the edge of the table while the leg hung freely. The knee was moved through 35 degrees of motion from 90 to 125 of knee flexion by CPM. The FFK and KFEH measured the flexibility of muscle and tendon. An electronic goniometer was placed on lateral side of the thigh leg to measure the degrees of knee flexion while passively moving the knee. The goniometer used a ruby bearing 360 degree 5000 ohm potentiometer ([Figure 2](#f2-medscimonit-19-1080){ref-type="fig"}). The output was digitized on BioPac MP 150 data collection system (BioPac System, Goleta, CA). The force needed to move the leg at 115 degrees of knee flexion was used to assess difference in FFK and KFEH.

The elastic hysteresis curve, which is the difference between the FFK and force to extend the knee (FEK), was also measured by CPM ([Figure 3](#f3-medscimonit-19-1080){ref-type="fig"}). Potential elastic energy stored during the loading (flexion) is greater than that of unloading (extension); thus, flexing the knee requires greater force than extending the knee \[[@b31-medscimonit-19-1080]\]. A lower elastic hysteresis value indicates more elasticity of the muscle and tendon.

Control of quadriceps and knee temperature
------------------------------------------

Quadriceps and knee temperature were controlled with Berg's polar care therapy heat exchange unit (Berg Inc. East Carlsbad, CA). Water temperature of the bath was maintained 40°C by a water bath. A heating water bath circulator (Fisher scientific Inc. Pittsburgh, PA) was attached to the water bath to control the water bath temperature. Since water temperature dropped about 2°C from the water bath to the therapy pad. Water temperature was kept at 40°C. This way each participant was given 38°C heat on their knee and quadriceps.

Procedures
----------

Participants signed an informed consent form prior to their involvement. All tests were performed seven times depending on each participant's menstrual phases throughout one full menstrual cycle. Since the estradiol serum concentration in blood and body temperature fluctuates during the day, the tests were performed at the same time each experiment day.

On the first day, physical characteristics were measured including height, weight, BMI, and self-reported menstrual cycle. Upon arriving to the examination area, participants rested comfortably in a regulated ambient temperature of 25°C for 20 minutes to stabilize their body temperature in a neutral environment. First, 4cc of blood samples were taken to analyze estradiol serum concentration before measuring leg skin temperature. Next, ACL elasticity, FFK, and KFEH were measured. After this, two 38°C heat pads were placed on each participant's quadriceps and knee for 20 minutes to control their leg temperature, skin temperatures, ACL elasticity, FFK, and KFEH measurements were repeated.

Data analysis
-------------

Kolmogrov-Smirnov test was conducted to examine the distribution of estradiol serum concentration, leg skin temperature, ACL elasticity, FFK, and KFEH. One-way repeated measures analysis of variance (ANOVA) was used to examine mean estradiol serum concentration, leg skin temperature, ACL elasticity, and the FFK at seven different phases in the menstrual cycle at ambient temperature. LSD pairwise comparisons test for multiple comparisons was used to compare means of variables between any two different testing phases. A mixed factorial ANOVA was conducted to compare cycle phases with respect to the effect of estradiol on ACL elasticity, FFK, and KFEH at ambient temperature and 38°C warming. The level of significance was set at p**\<**.05.

Results
=======

The distribution of estradiol serum concentration, leg skin temperature, ACL elasticity, FFK, and KFEH was approximately normal (p\>0.05). Mean and Standard Deviation (SD) of number of days, estradiol serum concentration, and leg skin temperature in seven different phases of the menstrual cycle is listed in [Table 2](#t2-medscimonit-19-1080){ref-type="table"}. The Participant's phases were determined by their self-report and estradiol serum concentration. Mean (SD) of the Anterior Tibial Displacement (ATD), FFK and KFEH at ambient temperature and 38°C warming in seven different testing phases during the menstrual cycle are shown in [Table 3](#t3-medscimonit-19-1080){ref-type="table"}.

Estradiol serum concentration
-----------------------------

As shown in [Figure 4](#f4-medscimonit-19-1080){ref-type="fig"}, estradiol concentrations significantly changed throughout the menstrual cycle (p\<0.001). The lowest estradiol concentration was found during menstruation (51.4±9.0 pg/ml) and the peak of estradiol concentration was found during ovulation (175.8±45.9 pg/ml, [Table 2](#t2-medscimonit-19-1080){ref-type="table"}).

Leg skin temperature
--------------------

Results indicated that there were no significant differences in knee and quadriceps skin temperatures during the menstrual cycle at ambient temperature (p\>0.05, [Table 2](#t2-medscimonit-19-1080){ref-type="table"}). However, there was a significant difference in knee skin temperature between the early follicular and the early luteal phase (31.4±0.4°C *vs.* 31.9±0.8°C, p=0.01). The quadriceps skin temperature was also significantly higher in the early luteal phase than early follicular phases (32.3±1.0°C *vs.* 31.5±0.5°C, p=0. 04). Leg skin temperature significantly increased and held at 38°C warming when two heat pads were applied on the knee and quadriceps.

Anterior knee ligament elasticity
---------------------------------

Anterior knee ligament elasticity was a measure of ATD. The greatest ATD during ovulation occurred both at ambient temperature and after 38°C warming ([Figure 5](#f5-medscimonit-19-1080){ref-type="fig"}). ATD during ovulation was significantly higher than any other phase at ambient temperature (p=.03). There was also a significant difference in ATD between menstruation and ovulation as well as between early follicular and menstruation at 38°C warming (p\<.05, [Table 3](#t3-medscimonit-19-1080){ref-type="table"}). The greatest ATD was observed when estradiol peaks while the opposite occurred with lower estradiol concentration across the seven phases during the menstrual cycle. There were significant differences in ADT between ambient temperature and 38°C warming during menstruation and early luteal phases ([Table 3](#t3-medscimonit-19-1080){ref-type="table"}).

Measurement of quadriceps muscle and tendon flexibility
-------------------------------------------------------

### Force to flex the knee (FFK)

The FFK decreased 15% from menstruation to ovulation at ambient temperature (p=0.4, [Table 3](#t3-medscimonit-19-1080){ref-type="table"}). However, no significant changes in FFK across the menstrual phases at 38°C warming were detected (p\>0.05, [Table 3](#t3-medscimonit-19-1080){ref-type="table"}). Also, a significant difference was found in the FFK in between the ambient temperature and 38°C warming all the phases except the ovulation and the middle luteal phase in which estradiol concentrations were relatively higher than other phases ([Table 3](#t3-medscimonit-19-1080){ref-type="table"}, [Figure 6](#f6-medscimonit-19-1080){ref-type="fig"}).

### Knee flexion-extension hysteresis (KFEH)

[Figure 4](#f4-medscimonit-19-1080){ref-type="fig"} shows the KFEH curve across the seven phases. As shown in [Figure 7](#f7-medscimonit-19-1080){ref-type="fig"}, there were significant differences of KFEH over the phases at ambient temperature. The KFEH increased 25% from ovulation to menstruation (26.0±6.0 N *vs.* 34.5±9.1 N, p\<0. 01), 15% from ovulation to the early luteal (26.0±6.0 N *vs.* 30.63±7.23 N, p=0. 04), and 13% from ovulation to the middle luteal phases (26.0±6.0 N *vs.* 29.97±6.98 N, p=0. 03). However, there were no significant changes in the KFEH over the phases at 38°C warming (p\>0.05). The KFEH was significantly higher at 38°C warming as compared to that at ambient temperature in all phases except the ovulation (P\<0. 05, [Figure 6](#f6-medscimonit-19-1080){ref-type="fig"}).

Discussion
==========

ACL injury is more common in women compared to men who participate in the same activities. Numerous studies have been conducted on changes of knee ligament elasticity during the menstrual cycle to examine the correlation between sex hormones, which fluctuate over the menstrual cycle, and ACL laxity \[[@b32-medscimonit-19-1080],[@b33-medscimonit-19-1080]\]. In spite of that, researchers are still debating on the results of these studies because the study methods and procedures were vastly different. Increased tissue temperature could be one factor that causes ligament and tendon laxness (Jarosch, 2011). In this investigation, ACL elasticity, FFK, and KFEH were measured during seven different phases of the menstrual cycle at ambient temperature and after warming the leg to 38°C in young healthy women with a regular menstrual cycle.

The most important finding of the present study was a significantly greater ACL elasticity, less FFK, and KFEH during ovulation where estradiol concentration peaks compared to the mensturation where estradiol level is lowest during the menstrual cycle. The relationship between sex hormones, especailly, estrogen and knee ligament elasticity as well as between estrogen and musculotendinous stifnesss in young women with a regular mentrual cycle, has been demonstrated \[[@b12-medscimonit-19-1080],[@b34-medscimonit-19-1080]--[@b36-medscimonit-19-1080]\]. However, this study is the first to examine the relationship between estradiol serum concentration and knee elasticity and its relationship to tissue temperature in young healthy women with a regular menstrual cycle. Greater ACL elasticity was found to occur during ovulation. There are two factors that may cause this: 1) estrogen and 2) tissue temperature. Heat is generally used to increase the elasicity and flexibility of soft tissues (LaBella et al., 2011). Ligaments must have more elasticity with relatively higher temperature since these are elastic stuctures. In this investigation, skin temperature was comparably lower during ovulation than mesntruation and the early follicular phase. But the only improtant temperature is the temperature of deep tissue. There are very few papers on deep shell tissue temperature in deep tissues during the menstrual cycle \[[@b21-medscimonit-19-1080]\]. These investigations found that muscle temperature was significantly elevated during ovulation and the well documented increase in core temperature. This is because heat has to be conserved by skin to get increased body temperature. Heat goes through the muscle and leaves the skin by radiation, convection, conduction, and evaporation. Skin needs to be cooler than the core temperature to aid in heat loss or conserve heat \[[@b24-medscimonit-19-1080]\]. Therefore, to keep the body cool at ovulation, the shell needs to remove more heat, hence muscle temperature increases at ovulation.

When the knee was heated to 38°C, there was still difference in ACL elasticity at ovulation when compared to other phases of the menstrual cycle. Therefore, while the temperature change in deep tissues causes increased laxness, so must estradiol. Both are synergistic at ovulation in increasing ACL elasticity. However, previous studies examining ACL elasticity did not control tissue temperature. Therefore, if it was a cool day, the cool temperature of the shell would increase ACL stiffness and its effect would be cancelled. Clothing and ambient temperature become important to consider in studies and may be the reason the results were so varied in different studies. No previous study has even had subjects acclimatized to room temperature before measuring measurements.

This study also measured the FFK and KFEH in knee felxion and extension. These measures examined muscle and tendon flexibility. Human muscles and tendons are soft tissues composed of collagen fibers which may be also affected by estradiol concentration and temperature as explained above. Results of this sutdy showed a significantly lower FFK and KFEH at ovulation compared to menstruation. This finding indicates that less muscle and tendon stiffness are shown in the ovulation than menstruation statge. In addition, this result may infer that less muscle flexibility occurs with increased estradiol concentration and lower skin temperature which may lead to higher muscle tissue temperautre in young healthy women. However, for the knee, the probable effect of estradiol is different. There was more energy storage at ovulation showing increased laxity. When the leg was warmed to the core temperature, this effect disappeared. This result implies that the flexibility is more affected by temperature than estrogen; although estrogen is responsible for the temperature fluctuation. Thus, using heat would be beneficial on increasing knee flexibility; the optimal time would be in the menstruation and early follicular phase, where the less flexibility occurs.

Knee joint stiffness is a major risk factor for non-contact ACL injuries \[[@b37-medscimonit-19-1080]\]. It is so common for athletes to do warm-up stretching or use heat packs to decrease stiffness before exercise for injury prevention \[[@b38-medscimonit-19-1080]\]. Women have greater knee stiffness due to estradiol and temperature effects during menstruation. However, this investigation did not examine how knee stiffness is related to injuries. Laxity may cause injuries or may not. Myklebust et al. and Slatuterbeck et al. reported that there are more ACL injuries during menstruation where less ACL elasticity was found \[[@b39-medscimonit-19-1080],[@b40-medscimonit-19-1080]\]. On the other hand, Wojtys et al. claimed that more ACL injuries occur during ovulation where greater ACL elasticity was found \[[@b41-medscimonit-19-1080]\]. However, these studies did not control environment or tissue temperature. Temperature may be another factor that affects ACL injuries but previous studies did not examine ACL elasticity under the same condition such as controlling the effects of clothing or environment temperature. If women play sports during ovulation in a hot environment, both temperature and estrogen causes excessive knee laxity which can leads to more knee injuries. However, if women play sports during menstruation in cold environments, both temperature and estrogen cause excessive knee stiffness which can lead to more knee injuries. Thus, in further investigation, both estrogen and temperature should be considered as key risk factors that can cause ACL injuries during menstrual cycle.

Conclusions
===========

ACL elasticity, FFK, and KFEH were affected not only by estradiol serum concentration but tissue temperature during the menstrual cycle. However, estradiol serum concentration had more impact on ACL laxity while tissue temperature had more impact on FFK and KFEH at 38°C warming.

**Source of support:** Departmental sources

![Experimental setup for ADT measured the ACL elasticity. The subject was positioned supine with their knee flexed to 25 degrees.](medscimonit-19-1080-g001){#f1-medscimonit-19-1080}

![Experimental setup for the FFK and KFEH measured the flexibility of muscle and tendon. The subject was positioned sit with their hip and knee flexed to 90 degrees.](medscimonit-19-1080-g002){#f2-medscimonit-19-1080}

![The elastic hysteresis curve, which is the difference between the FFK and for to extend the knee (FEK), was measured by CPM.](medscimonit-19-1080-g003){#f3-medscimonit-19-1080}

![Mean ±SD of estradiol serum concentration measured in 7 different phases during the menstrual cycle. M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.](medscimonit-19-1080-g004){#f4-medscimonit-19-1080}

![Mean ±SD of ATD measured in 7 different phases during the menstrual cycle at ambient temperature and 38°C warming. M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.](medscimonit-19-1080-g005){#f5-medscimonit-19-1080}

![Mean ±SD of the FFK measured in 7 different phases during the menstrual cycle at ambient temperature and 38°C warming. M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.](medscimonit-19-1080-g006){#f6-medscimonit-19-1080}

![Mean ±SD of KFEH measured across the 7 different phases during the menstrual cycle at ambient temperature and 38°C warming. M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.](medscimonit-19-1080-g007){#f7-medscimonit-19-1080}

###### 

Mean (SD) of general demographics (N=10).

              Age (years)   Height (cm)   Weight (kg)   BMI          Cycle length (d)
  ----------- ------------- ------------- ------------- ------------ ------------------
  Mean (SD)   24.7 (2.0)    164.6 (3.4)   57.1 (5.0)    21.0 (1.3)   29.5 (3.2)

SD -- standard deviation.

###### 

Summary of outcome variables in 7 different test phases during the menstrual cycle (N=10).

  Outcome measure                   M            EF            LF            O              EL                                                                                                                   ML                                                               LL                                                               p-value
  --------------------------------- ------------ ------------- ------------- -------------- -------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------- ---------
  Number of days                    2.2 (0.8)    6.3 (1.38)    10.2 (1.28)   14.2 (2.2)     17.8 (2.7)                                                                                                           23.4 (2.4)                                                       28.1 (3.2)                                                       \<0.001
  Estradiol, pg/ml                  51.4 (9.0)   68.3 (14.3)   82.5 (17.6)   175.8 (45.9)   103.9 (26.3)                                                                                                         130.3 (38.8)                                                     68.7 (17.0)                                                      \<0.001
  Knee skin temperature, °C         31.8 (0.7)   31.4 (0.4)    31.7 (1.0)    31.5 (0.8)     31.9[\#](#tfn3-medscimonit-19-1080){ref-type="table-fn"}[\*](#tfn4-medscimonit-19-1080){ref-type="table-fn"} (0.8)   31.8[\#](#tfn3-medscimonit-19-1080){ref-type="table-fn"} (0.5)   31.8[\#](#tfn3-medscimonit-19-1080){ref-type="table-fn"} (0.6)   0.39
  Quadriceps skin temperature, °C   31.8 (0.9)   31.5 (0.5)    31.8 (1.1)    31.6 (0.7)     32.1[\#](#tfn3-medscimonit-19-1080){ref-type="table-fn"}[\*](#tfn4-medscimonit-19-1080){ref-type="table-fn"} (1.0)   31.9[\#](#tfn3-medscimonit-19-1080){ref-type="table-fn"} (0.7)   31.9 (0.98)                                                      0.29

SD -- standard deviation; M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.

Significant changes from early follicular phase;

significant changes from ovulation phase.

###### 

Summary of biomechanical variables in 7 different test phases during the menstrual cycle at ambient temperature and 38°C warming (N=10).

  Phase                                                          ATD, mm                                                                                                             FFK, N                                                                                                              FKEH, N                                                                                                                                                                                                                                                                                     
  -------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- --------- ---------------------------------------------------------------------------------------------------------------------- -------------- -------- -------------------------------------------------------------------------------------------------------------------- ------------- --------
  M                                                              5.1 (1.5)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}   5.5 (1.6)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}   \<0.01    126.0 (35.4)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}   113.2 (23.8)   0.04     34.4 (9.1)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}   28.4 (8.0)    \<0.01
  EF                                                             5.4 (1.5)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}   5.5 (1.8)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       0.43      123.9 (34.2)                                                                                                           112.0 (31.3)   0.05     30.0 (8.7)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       26.9 (10.4)   0.07
  LF                                                             5.4 (5.9)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       5.6 (1.7)                                                                                                           0.24      116.6 (38.0)                                                                                                           110.9 (34.6)   0.01     28.9 (7.4)[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}                                                       25.0 (9.2)    0.03
  O                                                              5.9 (1.7)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       6.0 (1.8)                                                                                                           0.41      111.2 (24.6)                                                                                                           109.0 (25.9)   0.36     27.0 (6.0)                                                                                                           24.2 (8.7)    0.44
  EL                                                             5.4 (1.6)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       5.8 (1.7)                                                                                                           0.02      122.4 (31.9)                                                                                                           111.5 (31.2)   \<0.01   30.6 (7.2)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       25.5 (7.8)    0.05
  ML                                                             5.7 (1.7)[\^](#tfn6-medscimonit-19-1080){ref-type="table-fn"}                                                       5.8 (1.6)                                                                                                           0.66      115.2 (18.4)                                                                                                           108.9 (30.2)   0.2      30.0 (7.0)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       25.6 (5.3)    0.02
  LL                                                             5.2 (1.2)[\*](#tfn8-medscimonit-19-1080){ref-type="table-fn"}                                                       5.4 (1.0)                                                                                                           0.26      122.1 (27.7)                                                                                                           112.0 (27.4)   0.02     30.9 (9.1)                                                                                                           24.9 (6.8)    \<0.01
  p-value [b](#tfn10-medscimonit-19-1080){ref-type="table-fn"}   0.03                                                                                                                0.35                                                                                                                          0.2                                                                                                                    0.82                    0.06                                                                                                                 0.71          

SD -- standard deviation; M -- menstruation; EF -- early follicular; LF -- late follicular; O -- ovulation; EL -- early luteal; ML -- middle luteal; LL -- late luteal.

Significant changes from menstruation;

significant changes from early follicular phase;

significant changes from ovulation phase;

p-values for the null hypothesis that there is a no difference between pre and post heat;

p-values for the null hypothesis that there is a no difference across 7 phases of the menstrual cycle.
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